Evidence bases for this recommendation are the studies VISEP, CRYSTMAS, 6S, and CHEST [ 2 – 5 ], which showed a trend in the HES groups [ 2 , 3 , 5 ] or significance [ 4 ] for higher mortality and the need to employ renal replacement therapy significantly more frequently.
← all excerpts
Nephroprotective Potential of Human Albumin Infusion: A Narrative Review.
1
—
—